Background. The current US opioid epidemic is attributed to the large volume of prescribed opioids. This study analyzed the contribution of different medical specialties to overall opioids by evaluating the pill counts and morphine milligram equivalents (MMEs) of opioid prescriptions, stratified by provider specialty, and determined temporal trends.
Introduction
From 1999 through 2010, the number of opioid prescriptions in the United States increased dramatically [1, 2] . The rising toll of overdose deaths and substance use disorder treatment admissions closely mirrored the rate of increase of opioids dispensed [2] . There were multiple causes of increased prescribing, including a heightened focus on assessment and treatment of pain (e.g., the Joint Commission's pain initiative), aggressive and possibly fraudulent marketing by pharmaceutical companies, desire for providers and institutions to score highly on patient satisfaction scores, a small number of providers and pharmacies that prescribed and dispensed massive quantities of opioids for profit in an unprofessional and sometimes criminal fashion ("pill mills"), and a cultural shift that fostered unreasonable expectations of pain relief [3] [4] [5] [6] [7] [8] [9] [10] .
overdose deaths between 2013 and 2014 [11] . In particular, the rate of overdose death involving prescription opioid medications increased 9% from just 2013 to 2014. Furthermore, the vast majority of nonmedical users of opioid prescriptions get them from a friend or family for free [12] . Apart from medications that are illegally imported or stolen from pharmacies, prescribers need to recognize that the vast majority of non-medically used opioids are derived from a legitimate prescription.
To best target educational and policy efforts to reduce harm from opioid prescribing, it is helpful to have insight into the opioid prescribing practices within the different medical specialties. Prior research evaluating prescribing stratified by specialty type has been limited because investigators relied on data sets that estimate annual counts of prescriptions by specialty (e.g., IMS Health's National Prescription Audit), estimate numbers of prescriptions from a subset of pharmacies (e.g., the Vector One: National [VONA] database from SDI Health), or are limited to Medicare Part D or Medicaid beneficiaries [13] [14] [15] [16] [17] . Additionally, these studies did not report the number of pills and dose of opioid (morphine milligram equivalents [MMEs] ) per prescription and excluded large numbers of prescriptions such as for patients who selfpaid. The amount of opioid contained within each prescription is critical information as there is a doseresponse relationship with tolerance, addiction, and overdose [18] .
The aim of this study is to evaluate the opioid prescribing practices of each specialty to determine their impact on the total number of dispensed prescriptions for the pill forms of oral opioids, including over time. Using data from Ohio's prescription drug monitoring program (PDMP) database, we hypothesized that the contribution of physician specialties to opioid prescribing would differ if evaluated by number of pills and MMEs per prescription compared with only looking at the number of prescriptions.
Methods

Data Source and Study Population
This was a cross-sectional analysis of all prescriptions reported in the Ohio Automated Rx Reporting System (OARRS) database [19] between January 1, 2010, and December 31, 2014. This database captures nearly every controlled substance prescription that was dispensed in the state, regardless of payer (including selfpay), pharmacy, or location, with rare exception (e.g., prescriptions from Veterans Affairs hospitals). The Ohio PDMP is one of the few in the nation to link prescriber Drug Enforcement Administration (DEA) information to National Provider Identifier (NPI) data, which allows the determination of the prescriber's self-identified specialty. The study was deemed "not human research" by the Partners Healthcare Institutional Review Board.
Methods of Measurement
We extracted the following fields for each prescription from the Ohio PDMP data set: 1) name of drug, the dose, and the formulation (immediate vs extended release), 2) quantity of pills dispensed, 3) National Drug Code (generic identification of the medication), 4) unique identifier of prescriber, 5) first-listed prescriber specialty, 6) patient sex, 7) age of patient in years at time of dispensing, and 8) date the prescription was dispensed by the pharmacist.
We limited our analysis to solid dosing formulations of opioids, excluding patches. We studied the following opioids: codeine, demerol, hydrocodone, hydromorphone, methadone, morphine, oxycodone, oxymorphone, and tramadol. Prescriptions for buprenorphine (prescribed commonly for opioid use disorder) and tapentadol (rarely prescribed) and propoxyphene (discontinued during the study) were excluded. Physician specialty information is provided by practitioners when they apply for their state medical license. Providers are able to specify a primary, secondary, and tertiary specialty. For this analysis, we only considered primary specialty, which we grouped into categories (see the Appendix).
Statistical Analysis
MME was calculated using a previously published methodology [20] . Although PDMP data are generally rigorous, they do rely on correct entry by a pharmacist. To account for outliers in the data, we cleaned the data in the following fashion: 1) we excluded pill counts of less than four pills and equal to or greater than the 99% percentile for each specialty (N ¼ 809,651); 2) we eliminated all pill counts that were not integers (N ¼ 5,083); 3) we excluded prescriptions for patients younger than age five or older than age 99 years (N ¼ 46,449); 4) we excluded prescriptions with days' supply of 0 or less than 0 or more than 90 (N ¼ 11,970); and 5) we excluded prescriptions where patient sex was missing (N ¼ 25,499). In all, we excluded 898,652 records (1.6%) from analysis.
The primary outcomes of interest were the number of prescriptions (both total numbers and per prescriber) and median pill counts and MMEs per prescription for the opioid medications stratified by specialty. The secondary outcome was to determine temporal trends in opioid prescribing by specialty, reported on a yearly basis from 2010 to 2014. The population of Ohio stayed nearly constant during the study period (population 11,536,504 in 2010 and 11,594,163 in 2014), so we report overall pill counts rather than data normalized to the population [21] . The data were analyzed with SAS 9.4 and JMP 12.0 (SAS Institute, Inc., Cary, NC, USA).
Results
For the five years of the study period, there were a total of 56,873,719 prescriptions dispensed for pill formulations of hydrocodone (25, 027, 283) , oxycodone (16, 872, 828) , tramadol (9,493,003), codeine (2,307,900), morphine (1,513,600), methadone (815,298), hydromorphone (470,635), oxymorphone (333,237), and demerol (39,935) in Ohio. The mean patient age for the prescriptions was 51.7 years (SD ¼ 17.1), and 59.0% were for female patients. The total number of prescriptions per active ingredient per year for the six most commonly prescribed opioids is displayed in Figure Prescriber specialty information was available for 41,959,581 (73.8%) prescriptions. "Missing" specialty information includes nonphysician prescribers (e.g., dentists, nurse practitioners, physician assistants) as well as resident physicians and instances where the specialty of the physician was not provided. The numbers of prescriptions, mean and median numbers of pills per prescription, and mean and median numbers of MMEs per prescription are displayed in Table 1 . The number of pills and MMEs per prescription varied markedly between the specialties. Table 2 demonstrates the number of prescribers and average number of prescriptions per provider per year, as well as the use of extended-release medications. Prescriptions per prescriber varied markedly, from 18 prescriptions per year on average for pediatricians to 705 prescriptions per year by physical medicine/rehabilitation (PM&R). Likewise, utilization of extended-release medications was low for emergency medicine (1.0%) and gynecology (1.8%) but higher for hematology/oncology (25.6%), anesthesiology (25.0%), and PM&R (20.3%). Figure 2 demonstrates temporal trends in the mean numbers of MMEs per prescription, stratified by specialty type. The figure demonstrates that eight of the 11 studied specialties showed decreases over the study time frame. Neurology, specialty surgery, and particularly pediatrics had a trend toward increased MMEs per prescription over the five studied years, while the other specialties showed decreases.
Discussion
In Ohio, the contribution of physicians of each specialty to prescribed opioids varies markedly. This study represents a new way of evaluating the prescribing of opioids. Prior analyses focused on estimations of total numbers of prescriptions, but because pill counts per prescription and utilization of extended-release opioids vary, this analysis more accurately describes how prescribing behavior contributes to the volume of prescription opioids dispensed to the population. For example, emergency medicine was responsible for about 5% of the opioid prescriptions in our sample, but provided less than 2% of the total number of pills and MMEs. Furthermore, prescribing of extended-release formulations was low (0.5% of total prescriptions written by this specialty). Alternatively, the contribution of PM&R, for example, to total MMEs is actually about double its contribution to the number of prescriptions.
In all cases, when evaluating both the numbers of prescriptions and the numbers of pills and MMEs per prescription, it is evident that there are large differences both between the specialties and within the specialties themselves. The data in our study reporting numbers of prescriptions closely mirrors a recent analysis of the 2013 Medicare Part D data that discovered that pain medicine, anesthesiology, and PM&R had a disproportionately high level of prescribing per physician and that the bulk of overall opioid prescribing is by primary care physicians [16] . However, this prior study is limited because it did not report the pill count or dose of the prescribed opioid and Medicare beneficiaries are primarily elders (age 65 years) and those on hemodialysis, or suffering significant disability.
Recently, PDMP data has emerged as an important public health tool to determine prescribing behaviors [22] [23] [24] . Initial data from the Prescription Behavior Surveillance System has been used to determine prescribing differences in eight studied states [25] . The data show a wide range in rates of prescribing of controlled substances between states, and the surprising finding that the top 1% of prescribers was responsible for between 13.5% and 25.2% of all opioid prescriptions. However, the specialties of the prescribers were not identified, nor were temporal trends. A study from Utah manually linked NPI numbers to DEA numbers and evaluated opioid prescriptions (although not pill counts and MMEs) to prescriber specialty [26] . As in our study, they determined that family medicine and internal medicine wrote the largest proportion of prescriptions (30%) and were associated with about 40% of the prescription opioid-related fatalities. However, pain medicine and anesthesiology (considered to be different specialties in their study) were associated with a disproportionately higher attributable risk, supporting the importance of tracking prescriber specialty from a health outcomes perspective.
Our findings have three further implications with respect to PDMPs. PDMP data is beginning to be used to construct indicators of inappropriate prescribing for purposes of public health surveillance [27] . Such indicators include number of opioid prescriptions, overlapping prescriptions, multiple providers, and concurrent benzodiazepine use, as well as average daily MME dosage per patient. Currently, these indicators do not take prescriber specialty into account; our findings strongly suggest that they should. Second, several states have started issuing "prescriber report cards," which inform prescribers about their prescribing patterns relative to their specialty peers [28] . These reports are typically unsolicited reports that compare the controlled substance prescribing practices of different providers in a certain geographical area. Our findings reinforce the importance of comparing prescribing patterns within each specialty and not with all practitioners. Third, PDMP patient reports typically include a list of prescriptions the patient has filled over a period of time. While the number of prescriptions is readily apparent, the average daily or total dosage of opioid prescriptions is not. Our findings point to the importance of including, in the patient report, a calculation of current average daily opioid dosage and total opioid dosage over a defined period as these dosages may not be quickly inferred from the list of prescriptions. We discovered that the prescribing of hydrocodone from 2010 to 2014 decreased while prescriptions for oxycodone and tramadol increased. The decline in hydrocodone may be related to increased recognition of its abuse potential, leading to its recent rescheduling to category II [29] , and is a finding consistent with other prior work [30] . However, oxycodone may be more problematic than hydrocodone given that it has a markedly elevated abuse liability profile associated with its high likability scores and substantially fewer negative subjective effects as reported by users, so the trend is unfortunate [31] . The 41% increase in prescriptions for tramadol may represent an attempt to shift to a medication some consider a weaker or safer opioid [32] although the abuse potential of tramadol is still notable and abuse is increasing [33] .
The average number of MMEs per prescription dropped substantially for anesthesiology, which may represent increased awareness of the downside of opioid use and more cautious prescribing. But, of concern, there was a marked rise in MMEs per prescription by pediatricians.
Although the absolute numbers of prescriptions by pediatricians is low (only 0.3% of the total), this increase is notable and warrants further study.
Our trend results differ from another study that examined trends in the numbers of opioid prescriptions by specialty type from IMS Health's National Prescription Audit (NPA), which estimates the annual counts of prescriptions dispensed at retail pharmacies [13] . The study determined that from 2007 to 2012 the largest increase in numbers of opioid prescriptions was by PM&R (þ12.0%) and pain medicine (þ8.5%) and the largest decreases were by emergency medicine (-8.9%) and dentistry (-5.7%). Of note, our data set did not identify dentists, so a direct comparison to this previous study is not possible, but the differences in trends we sawdownwards for anesthesiology and PM&R, for example-may indicate that the numbers of opioid prescriptions peaked around 2010 to 2012 and now are down-trending given the heightened attention to opioid prescribing.
Certain specialties may prescribe higher amounts of opioids than others simply due to the patient population they see. For instance, the median number of pills was high (90 pills/prescription) for anesthesiology, hematology/oncology, neurology, and PM&R, likely indicative of these specialties' care of patients with chronic pain. Conversely, median pill counts for gynecology and pediatrics tended to be low (30 pills). Emergency medicine had the lowest median pill count of all the specialties (20 pills), which mirrors guidelines in place in Ohio and elsewhere that recommend only a three-to five-day supply of opioids from the ED setting [34, 35] . Emergency medicine also had the lowest MME per prescription, median 100 MMEs per prescription, which is just 13% of the highest prescriber, hematology/oncology.
Finally, we evaluated the percentage of opioid prescriptions for extended-release formulations, which have been more strongly associated with addiction and fatal overdose [36] . The use of extended-release formulations is highest for hematology/oncology (25.6% of total for specialty), anesthesiology (25.0%), and PM&R (20.3%). These formulations are typically prescribed for chronic pain, and thus it is not surprising that the specialists dealing most with chronic pain are the highest utilizers. Conversely, emergency medicine (1.0%), specialty surgery (1.7%), orthopedic surgery (1.7%), and gynecology (1.8%) rarely write prescriptions for these formulations, which is also consistent the more frequent treatment of acute, rather than chronic, pain by these providers.
Limitations
This study had several limitations. The database contained errors such as prescriptions for negative numbers of pills, zero pills, fractions of pills, or very high numbers of pills (>500). These numbers likely reflect errors in data entry from the pharmacies. For this reason, we cleaned the data, as described in the Methods section. However, this may have excluded prescriptions from specialties like hematology/oncology, which may have intentionally prescribed more than 90 days of pills per prescription. Furthermore, we decided to only study solid formulations of medications and did not consider suspensions (for which the concentrations were often truncated in the data set, making determination of MMEs impossible) and patches. We also did not include prescriptions for buprenorphine, tapentadol, and propoxyphene. Although these data are more accurate than previous data sets that relied on extrapolation, they only include prescriptions dispensed in Ohio and might not be representative of opioid prescribing in other states. Recent literature has found large differences in prescribing behaviors among practitioners in different states [25, 37] . The data set does not contain information from neighboring states or prescriptions that were written but not dispensed.
Determination of prescriber specialty is subject to variation. First of all, we only considered the primary specialty of the provider in our analysis and grouped the specialties into broad categories as described in the Appendix. As primary specialty is self-assigned and not necessarily practice location-specific (e.g., an internist working in an ED), there may be misclassifications in the data set. Prescriptions with missing specialty types also include nurse practitioners and physician assistants working alongside physicians, but their contribution could not be included in this analysis. There are other classification schemes in existence, such as the American Medical Society's specialty definition code list [38] . Other similar studies evaluating opioid prescribing by specialty did not include how they grouped specialties [11, 25] . Therefore, there may be differences in the results based on differences in classification. Finally, the data only extend to the end of 2014 and may not be indicative of more recent trends.
Conclusions
Stratifying opioid prescribing by specialty allowed us to identify each specialty's prescribing behaviors and recent trends. The additional element of pills and MMEs per prescription is a new analysis that much more accurately describes prescribing patterns. Prescribing trends vary markedly by specialty. Armed with this information, physician specialty leaders and policy makers should use this data to determine if prescribing amounts or patterns directly correspond to opioid-related harm and then prioritize interventions and research on efforts to reduce potentially inappropriate opioid prescribing within those specialty groups. 
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